Clinical Trial Detail

NCT ID NCT00892736
Title Veliparib in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

pancreatic cancer

prostate cancer

breast cancer

ovarian cancer

Therapies

Veliparib

Age Groups: adult

No variant requirements are available.